Cathepsin E is a specific marker of dysplasia in APCMin/+ mouse intestine

Lizette Busquets, Hector Guillen, Melanie E. DeFord, Mark A. Suckow, Rudolph M. Navari, Francis J. Castellino, Mary Prorok

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Transcriptional profiling of APCMin/+ mouse intestinal epithelial tissue has revealed that cathepsin E (catE) manifests high relative expression in adenomas and carcinomas relative to normal epithelium. Real-time RT-PCR data presented previously confirm the presence of catE transcript in APCMin/+ adenomatous cells compared with samples derived from normal APCMin/+ and wild-type tissue. At the protein level, strong, highly specific immunohistochemical staining for catE is displayed in dysplastic lesions of APCMin/+ mice. Using Western immunoblot analyses, it was additionally established that the urine of tumor-bearing mice contains higher levels of the monomeric form of catE than their wild-type counterparts. These results authenticate the relationship between transcript abundance and protein levels in transformed tissue and suggest potential utility for catE as a marker for the inception and progression of intestinal cancers.

Original languageEnglish
Pages (from-to)36-42
Number of pages7
JournalTumor Biology
Issue number1
StatePublished - Dec 2005


  • APC mice
  • Cathepsin E
  • Immunohistochemistry
  • Intestinal adenomas

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Cathepsin E is a specific marker of dysplasia in APCMin/+ mouse intestine'. Together they form a unique fingerprint.

Cite this